SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on June 25, 2021, covering events that occurred on June 24, 2021. The filing addresses the departure of a director and the subsequent appointment of the individual to a consulting role.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed relates to the compensation arrangement for the departing director:
- Stock Compensation: Grant of 16,310 fully vested restricted common shares and acceleration of 50,000 previously awarded restricted stock units.
- Consulting Retainer: Monthly base salary of $17,000 for a 12-month term.
- Service Obligation: Up to 20 hours of service per month, with payment guaranteed regardless of hours worked.
Material Changes
The primary material change is the resignation of Jeffrey F. O'Donnell, Sr. from the Board of Directors, effective immediately. This departure was not related to any dispute regarding the Company's operations, policies, or practices. Concurrently, the Company entered into a new contractual relationship with Mr. O'Donnell as a consultant.
Outlook, Risks, and Management Commentary
Management indicated that Mr. O'Donnell will continue to provide guidance on the Company's scientific and strategic initiatives under the new Availability Retainer Agreement. The filing explicitly states there are no disagreements between the departing director and the Company. No specific forward-looking guidance, risks, or contingencies regarding the Company's overall business operations were disclosed in this report.
Investor Verification Checklist
- Verify the total equity value of the 66,310 shares (16,310 new + 50,000 accelerated) granted to Mr. O'Donnell based on the stock price on June 24, 2021.
- Review the full text of the "Availability Retainer Agreement" (Exhibit 10.1) to understand specific deliverables and termination clauses.
- Confirm the impact of the $204,000 annual retainer ($17,000 x 12) on the Company's operating expenses for the fiscal year.
- Check subsequent filings to determine if a replacement director was appointed to the Board.